Literature DB >> 31985337

Differential Susceptibility of Xylella fastidiosa Strains to Synthetic Bactericidal Peptides.

Aina Baró1, Isabel Mora1, Laura Montesinos1, Emilio Montesinos1.   

Abstract

The kinetics of cell inactivation and the susceptibility of Xylella fastidiosa subspecies fastidiosa, multiplex, and pauca to synthetic antimicrobial peptides from two libraries (CECMEL11 and CYCLO10) were studied. The bactericidal effect was dependent on the relative concentrations of peptide and bacterial cells, and was influenced by the diluent, either buffer or sap. The most bactericidal and lytic peptide was BP178, an enlarged derivative of the amphipathic cationic linear undecapeptide BP100. The maximum reduction in survivors after BP178 treatment occurred within the first 10 to 20 min of contact and at micromolar concentrations (<10 μM), resulting in pore formation in cell membranes, abundant production of outer membrane vesicles, and lysis. A threshold ratio of 109 molecules of peptide per bacterial cell was estimated to be necessary to initiate cell inactivation. There was a differential susceptibility to BP178 among strains, with DD1 being the most resistant and CFBP 8173 the most susceptible. Moreover, strains showed a proportion of cells under the viable but nonculturable state, which was highly variable among strains. These findings may have implications for managing the diseases caused by X. fastidiosa.

Entities:  

Keywords:  Xylella fastidiosa; antimicrobial peptides; bactericidal activity; bacteriology; biochemistry and cell biology; disease control and pest management; v-qPCR; viable but nonculturable state

Year:  2020        PMID: 31985337     DOI: 10.1094/PHYTO-12-19-0477-R

Source DB:  PubMed          Journal:  Phytopathology        ISSN: 0031-949X            Impact factor:   4.025


  1 in total

1.  Screening and identification of BP100 peptide conjugates active against Xylella fastidiosa using a viability-qPCR method.

Authors:  Aina Baró; Esther Badosa; Laura Montesinos; Lidia Feliu; Marta Planas; Emilio Montesinos; Anna Bonaterra
Journal:  BMC Microbiol       Date:  2020-07-29       Impact factor: 3.605

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.